Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01727531 · ClinicalTrials.gov registry record · NA
IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy
A NA study, sponsored by Main Line Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01727531: Completed NA study, sponsored by Main Line Health.
NCT01727531 is a NA study that has completed, run by Main Line Health. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01727531, a NA study, has completed, sponsored by Main Line Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This research is being done to determine if a short course of Chloroquine (five weeks) before, during and after whole brain radiation therapy (WBRT) will improve the overall survival of subjects being treated for brain metastases.
Primary Outcome
Determine patients physical profiles prior WBRT and at regular intervals afterwards up to 24 months after radiotherapy
Interventions
- DRUG Chloroquine diphosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01727531 record still lists
NCT01727531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Chloroquine diphosphate is the first listed.
NCT01727531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01727531 about?
NCT01727531 is a clinical study titled "IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy". This research is being done to determine if a short course of Chloroquine (five weeks) before, during and after whole brain radiation therapy (WBRT) will improve the overall survival of subjects being treated for brain metastases.
What is the current status of trial NCT01727531?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2008-12. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01727531?
The interventions under investigation include: Chloroquine diphosphate (DRUG).
Who is sponsoring clinical trial NCT01727531?
This trial is sponsored by Main Line Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01727531's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia